Open Access

[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2

  • Authors:
    • Lei Xu
    • Bin Zhang
    • Wenlan Li
  • View Affiliations

  • Published online on: July 30, 2024     https://doi.org/10.3892/mmr.2024.13297
  • Article Number: 173
  • Copyright : © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Mol Med Rep 23: [Related article:] 263, 2021; DOI: 10.3892/mmr.2021.11902

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the immunohistochemical data shown in Fig. 1D and the flow cytometric data in Fig. 3K were strikingly similar to data appearing in different form in other papers by different authors at different research institutes that were under consideration for publication at around the same time.

Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

October-2024
Volume 30 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Zhang B and Li W: [Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Mol Med Rep 30: 173, 2024.
APA
Xu, L., Zhang, B., & Li, W. (2024). [Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Molecular Medicine Reports, 30, 173. https://doi.org/10.3892/mmr.2024.13297
MLA
Xu, L., Zhang, B., Li, W."[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2". Molecular Medicine Reports 30.4 (2024): 173.
Chicago
Xu, L., Zhang, B., Li, W."[Retracted] Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2". Molecular Medicine Reports 30, no. 4 (2024): 173. https://doi.org/10.3892/mmr.2024.13297